
Join to View Full Profile
- 25 valley roadMadison, NJ 07940 
- Phone+1 908-337-5844 
Dr. Haverty is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
 University of Pennsylvania Health SystemFellowship, Nephrology, 1983 - 1987 University of Pennsylvania Health SystemFellowship, Nephrology, 1983 - 1987
 University of Pennsylvania Health SystemResidency, Internal Medicine, 1980 - 1983 University of Pennsylvania Health SystemResidency, Internal Medicine, 1980 - 1983
 University of California San Diego School of MedicineClass of 1980 University of California San Diego School of MedicineClass of 1980
Certifications & Licensure
 NJ State Medical License 1991 - 2027 NJ State Medical License 1991 - 2027
 CA State Medical License 1996 - 2026 CA State Medical License 1996 - 2026
 PA State Medical License 1982 - 2026 PA State Medical License 1982 - 2026
 AL State Medical License 1989 - 1991 AL State Medical License 1989 - 1991
 American Board of Internal Medicine Internal Medicine American Board of Internal Medicine Internal Medicine
 American Board of Internal Medicine Nephrology American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- 84 citationsRebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti–IL-5 antibody SCH55700Yae-Jean Kim, Calman Prussin, Brian Martin, Melissa A. Law, Thomas P. Haverty
 The Journal of Allergy and Clinical Immunology. 2004-12-01
- 130 citationsSafety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome.Amy D. Klion, Melissa A. Law, Pierre Noel, Yae Jean Kim, Thomas P. Haverty
 Blood. 2004-04-15
- 36 citationsPhase I Evaluation of Humanized OKT3 Toxicity and Immunomodulatory Effects of hOKT3γ4Jon M. Richards, Julie A. Auger, Donna Peace, Danielle Gale, Judy Michel
 Cancer Research. 1999-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









